[HTML][HTML] Assessment of therapeutic bio-activity of cinnamoyl sulfonamide hydroxamate in squamous cell carcinoma
Background Cancer is the second most common cause of death. Oral squamous cell
carcinoma (OSCC) represents the most frequent of all oral neoplasms. Many treatment …
carcinoma (OSCC) represents the most frequent of all oral neoplasms. Many treatment …
In vitro and in vivo evaluation of novel cinnamyl sulfonamide hydroxamate derivative against colon adenocarcinoma
The potential of cinnamic acid as an anti-inflammatory and anti-cancer agent has been
studied previously. In our investigation, novel bio-isosters of cinnamyl sulfonamide …
studied previously. In our investigation, novel bio-isosters of cinnamyl sulfonamide …
An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDACáinhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells
Multiple genetic mutations along with unusual epigenetic modifications play a major role in
cancer development. Histone deacetylase (HDAC) enzyme overexpression observed in the …
cancer development. Histone deacetylase (HDAC) enzyme overexpression observed in the …
Synthesis and cytotoxic activities of difluoro-dimethoxy chalcones
Background: Although anticancer chemotherapeutics are available in markets, side effects
related to the drugs in clinical use lead to researchers to investigate new drug candidates …
related to the drugs in clinical use lead to researchers to investigate new drug candidates …
[HTML][HTML] In vitro and in vivo anticancer studies of 2'-hydroxy chalcone derivatives exhibit apoptosis in colon cancer cells by HDAC inhibition and cell cycle arrest
AN Pande, S Biswas, ND Reddy, BS Jayashree… - EXCLI …, 2017 - ncbi.nlm.nih.gov
Considering the therapeutic values of bioflavonoids in colon cancer treatment, six 2ʹ-
hydroxy chalcones (C1-C6) were synthesized, characterized and screened for in vitro …
hydroxy chalcones (C1-C6) were synthesized, characterized and screened for in vitro …
1'-Acetoxychavicol acetate inhibits growth of human oral carcinoma xenograft in mice and potentiates cisplatin effect via proinflammatory microenvironment alterations
Background Oral cancers although preventable, possess a low five-year survival rate which
has remained unchanged over the past three decades. In an attempt to find a more safe …
has remained unchanged over the past three decades. In an attempt to find a more safe …
Therapeutic applications of herbal/synthetic/bio-drug in oral cancer: An update
SA Mosaddad, K Beigi, T Doroodizadeh… - European Journal of …, 2021 - Elsevier
Oral cancer, as one of the most prevalent and invasive cancers that invade local tissue, can
cause metastasis, and have high mortality. In 2018, around 355,000 worldwide oral cancers …
cause metastasis, and have high mortality. In 2018, around 355,000 worldwide oral cancers …
Preparation And In Vitro Anticancer Activity Evaluation Of Some Coumarin Derivatives
Cancer has become the second main reason for worldwide disease-related deaths [1].
According to the key fact sheet of WHO (Accessed on May 1, 2019, https://www. who …
According to the key fact sheet of WHO (Accessed on May 1, 2019, https://www. who …
Sulforaphane inhibits histone deacetylase causing cell cycle arrest and apoptosis in oral squamous carcinoma cells
M Krishnan, S Saraswathy, S Singh, GK Saggu… - Medical Journal Armed …, 2022 - Elsevier
Background Biologic compounds have recently generated interest in cancer
chemoprevention. Sulforaphane (SFN), an isothiocyanate from cruciferous vegetables, has …
chemoprevention. Sulforaphane (SFN), an isothiocyanate from cruciferous vegetables, has …
Pro-Apoptotic Antitumoral Effect of Novel Acridine-Core Naphthoquinone Compounds against Oral Squamous Cell Carcinoma
BC Zorzanelli, G Ouverney, FP Pauli, ACC da Fonseca… - Molecules, 2022 - mdpi.com
Oral squamous cell carcinoma (OSCC) is a global public health problem with high incidence
and mortality. The chemotherapeutic agents used in the clinic, alone or in combination …
and mortality. The chemotherapeutic agents used in the clinic, alone or in combination …